Annals of Surgical Oncology

, Volume 12, Issue 1, pp 3–5 | Cite as

Reducing the Need for Sentinel Node Procedures by Ultrasound Examination of Regional Lymph Nodes

Editorial

References

  1. 1.
    Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol (in press)Google Scholar
  2. 2.
    Garbe, C, Paul, A, Kohler-Spath, H,  et al. 2003Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategyJ Clin Oncol215209Google Scholar
  3. 3.
    Kanter, AY, Eijck, CH, Geel, AN,  et al. 1999Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancerBr J Surg86145962Google Scholar
  4. 4.
    Sato, K, Tamaki, K, Tsuda, H,  et al. 2004Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsyAm J Surg18767983Google Scholar
  5. 5.
    Deurloo, EE, Tanis, PJ, Gilhuijs, KG,  et al. 2003Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancerEur J Cancer39106873CrossRefGoogle Scholar
  6. 6.
    Rossi, CR, Mocellin, S, Scagnet, B,  et al. 2003The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patientsJ Surg Oncol83804Google Scholar
  7. 7.
    Essner, R, Chung, MH, Bleicher, R, Hsueh, E, Wanek, L, Morton, DL 2002Prognostic implications of thick (>or=4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomyAnn Surg Oncol975461Google Scholar
  8. 8.
    Mozzillo, N, Caraco, C, Chiofalo, MG,  et al. 2004Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-upEur J Surg Oncol304403Google Scholar
  9. 9.
    Carlson, GW, Murray, DR, Hestley, A, Staley, CA, Lyles, RH, Cohen, C 2003Sentinel lymph node mapping for thick (>=4-mm) melanoma: should we be doing it? Ann Surg Oncol10408415Google Scholar
  10. 10.
    Thompson, JF, Shaw, HM 2002The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome? Ann Surg Oncol975461Google Scholar
  11. 11.
    Kirkwood, JM, Manola, J, Ibrahim, J, Sondak, V, Ernstoff, MS, Rao, U 2004A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanomaClin Cancer Res1016707Google Scholar
  12. 12.
    Wheatley, K, Ives, N, Hancock, B, Gore, M, Eggermont, AMM, Suciu, S. 2003Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trialsCancer Treat Rev2924152Google Scholar
  13. 13.
    Eggermont, AMM, Gore, M. 2002European approach to adjuvant treatment of intermediate- and high-risk malignant melanomaSemin Oncol293828Google Scholar
  14. 14.
    Spitler, LE. 2002Adjuvant therapy of melanomaOncology 16S408Google Scholar
  15. 15.
    Eggermont, AMM, Keilholz, U, Testori, A, Cook, M, Lienard, D, Ruiter, DJ 2001The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of CancerAnn Surg Oncol838S40SGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2005

Authors and Affiliations

  1. 1.Department of Surgical OncologyErasmus University Medical Center–Daniel den Hoed Cancer CenterRotterdamThe Netherlands

Personalised recommendations